Fort Washington Investment Advisors Inc. OH Raises Position in Maximus, Inc. $MMS

Fort Washington Investment Advisors Inc. OH increased its position in shares of Maximus, Inc. (NYSE:MMS) by 4.3% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 343,727 shares of the health services provider’s stock after purchasing an additional 14,180 shares during the period. Fort Washington Investment Advisors Inc. OH’s holdings in Maximus were worth $29,671,000 as of its most recent SEC filing.

A number of other hedge funds have also recently added to or reduced their stakes in the company. Dimensional Fund Advisors LP boosted its holdings in Maximus by 2.0% in the 3rd quarter. Dimensional Fund Advisors LP now owns 1,869,573 shares of the health services provider’s stock valued at $170,812,000 after purchasing an additional 36,989 shares in the last quarter. Boston Partners grew its holdings in Maximus by 47.0% during the third quarter. Boston Partners now owns 966,139 shares of the health services provider’s stock worth $88,236,000 after acquiring an additional 308,892 shares during the period. Reinhart Partners LLC. grew its holdings in Maximus by 0.8% during the third quarter. Reinhart Partners LLC. now owns 921,578 shares of the health services provider’s stock worth $84,206,000 after acquiring an additional 7,722 shares during the period. Stephens Investment Management Group LLC raised its position in Maximus by 49.0% in the third quarter. Stephens Investment Management Group LLC now owns 720,943 shares of the health services provider’s stock worth $65,873,000 after acquiring an additional 237,097 shares in the last quarter. Finally, Federated Hermes Inc. raised its position in Maximus by 1.3% in the third quarter. Federated Hermes Inc. now owns 688,505 shares of the health services provider’s stock worth $62,909,000 after acquiring an additional 8,847 shares in the last quarter. Institutional investors and hedge funds own 97.21% of the company’s stock.

Maximus Stock Performance

NYSE MMS opened at $65.05 on Friday. Maximus, Inc. has a 1-year low of $64.66 and a 1-year high of $100.00. The company has a market capitalization of $3.55 billion, a P/E ratio of 9.90 and a beta of 0.59. The business has a 50 day moving average price of $79.22 and a 200 day moving average price of $84.33. The company has a debt-to-equity ratio of 0.88, a current ratio of 2.34 and a quick ratio of 2.34.

Maximus (NYSE:MMS) last posted its earnings results on Thursday, February 5th. The health services provider reported $1.85 EPS for the quarter, topping analysts’ consensus estimates of $1.84 by $0.01. The company had revenue of $1.35 billion for the quarter, compared to the consensus estimate of $1.37 billion. Maximus had a return on equity of 25.30% and a net margin of 6.92%.Maximus’s quarterly revenue was down 4.1% compared to the same quarter last year. During the same period in the previous year, the business earned $1.61 earnings per share. Maximus has set its FY 2026 guidance at 8.050-8.350 EPS. Sell-side analysts expect that Maximus, Inc. will post 6.15 EPS for the current fiscal year.

Maximus Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Monday, March 2nd. Investors of record on Friday, February 13th were given a $0.33 dividend. The ex-dividend date was Friday, February 13th. This represents a $1.32 annualized dividend and a dividend yield of 2.0%. This is a boost from Maximus’s previous quarterly dividend of $0.30. Maximus’s payout ratio is presently 20.09%.

Insider Activity at Maximus

In other Maximus news, CFO David Mutryn bought 1,000 shares of the business’s stock in a transaction on Monday, February 9th. The stock was bought at an average price of $75.62 per share, for a total transaction of $75,620.00. Following the completion of the transaction, the chief financial officer owned 40,037 shares in the company, valued at approximately $3,027,597.94. The trade was a 2.56% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Jan Madsen sold 742 shares of the company’s stock in a transaction dated Tuesday, March 17th. The shares were sold at an average price of $72.25, for a total transaction of $53,609.50. Following the completion of the sale, the director directly owned 20,795 shares in the company, valued at $1,502,438.75. This trade represents a 3.45% decrease in their position. The SEC filing for this sale provides additional information. 1.80% of the stock is owned by corporate insiders.

Analyst Ratings Changes

Several brokerages have commented on MMS. Wall Street Zen lowered shares of Maximus from a “buy” rating to a “hold” rating in a research report on Monday, February 23rd. Weiss Ratings downgraded shares of Maximus from a “buy (b)” rating to a “hold (c+)” rating in a report on Tuesday, February 24th. Finally, Zacks Research upgraded shares of Maximus from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, December 30th. One equities research analyst has rated the stock with a Strong Buy rating and one has assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Buy”.

About Maximus

Maximus, Inc (NYSE: MMS) is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children’s Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.